The Role of Epstein-Barr Virus in Burkitt’s Lymphoma
Reference29 articles.
1. Brade, L., Müller-Lantzsch, N., and zur Hausen, H. B-lymphotropic papovavirus and possibility of infections in humans. J. Med. Virol. 6, 301–308, 1980. 2. Brade, L., Vogl, W., Gissmann, L., and zur Hausen, H. Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA. Virology 114, 228–235, 1981. 3. de Thé, G., Geser, A., Day, N.E., Tukei, P.M., Williams, E.H., Beri, D.P., Smith, P.G., Dean, A.G., Bornkamm, G.W., Feorino, P., and Henle, W. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature 274, 756–761, 1978. 4. Diehl, V., Krause, P., Hellriegel, K.P., Busche, M., Schedel, I., and Laskewitz, E. In: Immunological Diagnosis of Leukemias and Lymphomas. Thierfelder, T., Rodt, H., and Thiel, E. (eds.). Springer-Verlag, Berlin and New York, pp. 289–296, 1977. 5. Epstein, M.A., Achong, B.G., and Barr, Y.M. Virus particles in cultured lymphoblasts from Burkitt1s lymphoma. Lancet I, 702–703, 1964.
|
|